KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Invested Capital (2020 - 2025)

GoodRx Holdings' Return on Invested Capital history spans 6 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, up 1.0%, while the annual FY2025 figure was 0.04%, 1.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.04% at GoodRx Holdings, down from 0.04% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q3 2024 and bottomed at 0.4% in Q1 2021.
  • The 5-year median for Return on Invested Capital is 0.0% (2023), against an average of 0.05%.
  • The largest YoY upside for Return on Invested Capital was 40bps in 2021 against a maximum downside of -78bps in 2021.
  • A 5-year view of Return on Invested Capital shows it stood at 0.04% in 2021, then plummeted by -94bps to 0.0% in 2022, then tumbled by -235bps to 0.0% in 2023, then skyrocketed by 1079bps to 0.03% in 2024, then surged by 50bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Return on Invested Capital are 0.04% (Q4 2025), 0.04% (Q3 2025), and 0.05% (Q2 2025).